Back to BCRX
Hennion & Walsh Asset Management, Inc. → BCRX
Hennion & Walsh Asset Management, Inc. BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$954K
Q3 2026
Peak value
$1.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $651K |
| Q4 2025 | $878K |
| Q1 2026 | $1.1M |
| Q2 2026 | $1.1M |
| Q3 2026 | $954K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $954K | 114.5K | — | — |
| Q2 2026 | $1.1M | 112.9K | — | — |
| Q1 2026 | $1.1M | 113.9K | — | — |
| Q4 2025 | $878K | 112.5K | — | — |
| Q3 2025 | $651K | 85.7K | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$151.9M
$151.9M
$116.2M